Product Overview
[Drug Name]
Generic Name: Cerebroprotein Hydrolysate Tablets
Trade Name: Gulixi
English Name: Cerebroprotein Hydrolysate Tablets
Chinese Pinyin: Naodanbai Shuijiewu Pian
[Ingredients]
This product is a hydrolyzed peptide extracted from fresh brain tissue of healthy pigs. It contains various amino acids, cephalin, phosphatidylcholine, and peptide nerve growth factor.
[Properties]
This product is a film-coated tablet. After removing the film coating, it appears brownish-yellow.
[Indications]
It is used to relieve symptoms such as insomnia, headache, memory loss, dizziness, and irritability, and to promote recovery from acute cerebral infarction and acute brain trauma.
[Dosage]
Adults: 2-4 tablets three times daily. Children: Reduce dosage or follow doctor's advice.
[Adverse Reactions]
No adverse reactions have been reported.
[Contraindications]
This product is contraindicated in the following situations: 1. Hypersensitivity to any of the ingredients in this product. 2. Status epilepticus. 3. Grand mal seizures. Use of this product in these situations may increase the frequency of seizures. 4. Patients with severe renal insufficiency.
[Precautions]
If an allergic reaction occurs, discontinue the drug immediately and seek prompt medical attention.
[Use in Special Populations]
Precautions for Children:
Children should reduce the dosage of this product as needed or follow a doctor's advice. Other information is not available.
Precautions for Pregnancy and Lactation:
Pregnant and lactating women are contraindicated.
Precautions for Elderly:
Elderly patients are the primary target population for this product, but its safety profile has not been definitively documented. During clinical use, close observation should be made and the dosage should be appropriately reduced or as directed by a doctor.
[Drug Interactions]
1. Protein hydrolysate injection should not be administered in the same bottle as amino acid injection. When amino acid infusions are administered simultaneously, caution should be exercised regarding the potential for amino acid imbalance. 2. Co-administration with antidepressants may result in adverse interactions, leading to inappropriate mental stress. In such cases, a reduction in the antidepressant dosage is recommended.
[Pharmacological Actions]
This product is a peptidergic neurotrophic drug specific to the brain. It acts on the central nervous system in various ways, regulating and improving neuronal metabolism, promoting synaptic formation, inducing neuronal differentiation, and further protecting nerve cells from various ischemic and neurotoxin damage. It can cross the blood-brain barrier, promote protein synthesis in the brain, influence the respiratory chain, protect against hypoxia, and improve brain energy metabolism. It activates adenylate cyclase and catalyzes other hormone systems. It provides neurotransmitters, peptide hormones, and coenzyme precursors.
Storage: Store tightly closed in a cool, dry place.
Specifications: 6.5mg (calculated as amino nitrogen): 14.4mg (calculated as total nitrogen)
Packaging: 6.5mg: 14.4mg (24s)/box
Expiration Period: 24 months
Approval Number: National Medicine Standard H23023288
Manufacturer: Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
